Private Equity Firm Healthcare

Patient Square Capital

Menlo Park, California, United States

Dedicated healthcare investment firm that partners with management teams to grow healthcare businesses; invests in products, services, and technologies that improve health and patient lives.

Focus Areas
Healthcare investment, Healthcare services, Healthcare technology

Tracked deals

12

12 tracked deals across 2021-2026.

Recent pace

3

3 tracked deals announced in the last 12 months.

Deal mix

Buyout

9 buyout · 2 growth capital · 1 recapitalization

Patient Square Capital Acquisition Volume by Year

Last 6 years

Acquisition volume by year Annual acquisition counts for the last 6 years for Patient Square Capital. 1 2021 4 2022 1 2023 1 2024 4 2025 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Patient Square Capital
    Target
    Paradigm
    Seller
    OMERS Private Equity
    Type
    Buyout

    Paradigm, a specialty care management organization focused on complex injuries and diagnoses, has entered into a definitive agreement to be acquired by Patient Square Capital. The transaction is expected to close in the first half of 2026, marking the conclusion of Paradigm’s partnership with OMERS Private Equity.

  • Buyer
    Patient Square Capital
    Target
    Premier, Inc.
    Type
    Buyout

    Patient Square Capital (via an affiliate) has completed its previously announced $2.6 billion acquisition of Premier, Inc., valuing Premier at $2.6 billion. Premier common stock stopped trading and will be delisted from Nasdaq as of November 25, 2025, with stockholders receiving $28.25 in cash per share.

  • Buyer
    Patient Square Capital
    Target
    Premier, Inc.
    Type
    Buyout

    Premier, Inc. stockholders overwhelmingly approved Patient Square Capital’s acquisition of the company at a special meeting. The deal provides Premier shareholders $28.25 in cash per share and is expected to close on or about November 25, 2025, subject to customary closing conditions.

  • Buyer
    Patient Square Capital, Patient Square Equity Partners, LP
    Target
    Patterson Companies, Patterson Companies Inc.
    Type
    Buyout

    Patterson Companies entered into a definitive agreement to be acquired by Patient Square Capital in a $4.1 billion transaction (about $31.35 per share in cash). The acquisition completed on April 17, 2025, and Patterson’s common stock is no longer traded on the Nasdaq Global Select Market.

  • Buyer
    Patient Square Capital
    Target
    Eargo, hearX (Lexie Hearing)
    Industry
    Medical Devices

    Eargo and hearX (maker of Lexie Hearing) have completed a merger to form LXE Hearing, combining their consumer hearing-aid brands and technology platforms. The transaction is backed by an additional $100 million investment from Patient Square Capital to support growth, product integration and expanded access in the OTC hearing-aid market.

  • Buyer
    Patient Square Capital, The Carlyle Group
    Target
    CorroHealth

    CorroHealth, a Plano-based provider of clinically led revenue cycle management (RCM) and healthcare analytics, has signed definitive agreements for a strategic investment from Patient Square Capital. Current shareholders including Carlyle will remain investors, and Patient Square and Carlyle will share joint control as CorroHealth pursues further organic and inorganic growth.

  • Buyer
    Elliott Investment Management L.P., Patient Square Capital, Veritas Capital
    Target
    Syneos Health, Inc.
    Seller
    Syneos Health stockholders
    Type
    Buyout

    A consortium of private investment firms—Elliott Investment Management, Patient Square Capital and Veritas Capital—has completed the acquisition of Syneos Health for $43.00 per share, a transaction valued at approximately $7.1 billion including debt. Syneos Health will become a privately held company, with the new owners planning to accelerate its transformation, invest in technology and strengthen its integrated biopharmaceutical services.

  • Buyer
    Patient Square Capital
    Target
    Eargo, Inc.
    Industry
    Medical Devices

    Patient Square Capital became the majority equity owner of Eargo, Inc. after converting its senior secured convertible notes and participating in Eargo’s rights offering. The transaction leaves Eargo debt-free, gives Patient Square approximately 76.3% of outstanding common stock, and raises roughly $32.3 million of net proceeds to support working capital and the company’s omni-channel growth strategy.

  • Buyer
    Patient Square Capital
    Target
    Hanger, Inc.
    Type
    Buyout

    Hanger, Inc. announced it has completed its previously announced acquisition by Patient Square Capital in an all-cash deal. Hanger stockholders received $18.75 per share and Hanger became a private company, with its NYSE listing removed.

  • Buyer
    Gurnet Point Capital, Patient Square Capital, OrbiMed Advisors, LLC
    Target
    Radius Health, Inc.
    Seller
    Radius Health shareholders
    Type
    Buyout

    Gurnet Point Capital and Patient Square Capital entered into a definitive agreement to acquire Radius Health in a transaction valued at approximately $890 million, including the assumption of debt. The offer is $10.00 per share in cash plus a $1.00 per share contingent value right (CVR) tied to TYMLOS (abaloparatide) net sales reaching $300 million during a 12-month period prior to December 31, 2025.

  • Buyer
    Patient Square Capital
    Target
    SOC Telemed, Inc.
    Seller
    SOC Telemed stockholders
    Type
    Buyout

    Patient Square Capital agreed to acquire SOC Telemed, Inc., the largest U.S. provider of acute care telemedicine, in an all-cash transaction valuing SOC Telemed at $3.00 per share. The deal takes SOC Telemed private and will provide capital and industry expertise to expand the company’s clinical capabilities, innovate its Telemed IQ platform and grow its footprint across hospitals, post-acute and value-based care organizations.

  • Buyer
    Patient Square Capital
    Target
    Summit BHC
    Seller
    FFL Partners, Lee Equity Partners
    Type
    Buyout

    Patient Square Capital has acquired Summit BHC, a Franklin, Tennessee–headquartered provider of behavioral health and addiction treatment services that operates 24 facilities across 16 states. Summit was sold by private equity owners FFL Partners and Lee Equity Partners; financial terms were not disclosed and the deal was announced in September 2021 and closed in November 2021.

Related Acquisition Pages

Selling a company? Get in front of buyers like Patient Square Capital

Turn tracked acquisition activity into an outreach-ready buyer list.